A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke
NCT05953480
Acute Ischemic Stroke, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT Number: NCT01021319
The aim of the study is to evaluate the use of combined fluid attenuated inversion recovery (FLAIR) imaging and diffusion weighted imaging (DWI) as surrogate marker of lesion age within the first 6 hours of ischemic stroke in order to identify patients ≤ 3 or ≤ 4.5 hours of symptom onset in a large multicenter study hours of ischemic stroke. The investigators hypothesize that the pattern of a visible lesion on DWI together with a negative FLAIR ("DWI-FLAIR mismatch") will identify patients ≤ 3 hours of symptom onset with >80% specificity and positive predictive value.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Charite Clinical Center, Berlin, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: on admission
Time frame: on admission
Götz Thomalla, MD
Other
PREdictive Value of FLAIR and DWI for the Identification of Acute Ischemic Stroke Patients ≤ 3 and ≤ 4.5 h of Symptom Onset - a Multicenter Observational Study
Acronym: PRE-FLAIR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05953480
Acute Ischemic Stroke, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05965687
Acute Ischemic Stroke, Brain Diseases
Beijing, China
View Trial DetailsNCT06101667
Acute Ischemic Stroke, Basilar Artery Occlusion
Beijing, Beijing Municipality, China
View Trial DetailsNCT06638151
Acute Ischemic Stroke, Brain Diseases
Edmonton, Alberta, Canada
View Trial Details